Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Antibody Drug Conjugate Global Market Report based on Analysis, Size, Share, Growth, Trends, Competitive Landscape and Forecast

Friday, November 11, 2016 3:38
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Market research future published a half-cooked research report on Global Antibody Drug Conjugate Market Information by types, Applications, by end users, Forecast to 2027


Market Scenario:

Antibody Drug Conjugates are ADCs are empowered antibodies (mAbs) designed to harness the targeting ability of monoclonal antibodies by linking them to cell-killing agents. The unique property of ADCs is that it selectively dispatch highly potent cytotoxic anticancer chemotherapies directly to cancer cells while, at the same time, leaving healthy tissue unaffected. The ADCs market has been one of the most actively evolving markets over the course of last few years and comprises a multitude of therapies that can be potentially exploited for a broad range of cancer indications. ADCs for refractory Hodgkin Lymphoma and metastatic breast cancer are already present in market.  Besides this, ADCs can be developed for the treatment of cancers including prostate, kidney, pancreas, ovary, lung, colon and skin. The Antibody Drug Conjugate Market is expected to reach US$ XX by the end of the forecasted period and is expected to grow at a CAGR of XX%


“Ask for your specific company profile and country level customization on reports.”

Key Players

  • Seattle Genetics (US)
  • ImmunoGen, Inc.(US)
  • Roche Holding AG (Switzerland)
  • Genentech (US)
  • Concortis Biotherapeutics (US)
  • Agensys, Inc. (US)
  • Antikor (UK)


Get a Sample Report @



By Applications

  • Prostate
  • Kidney
  • Pancreas
  • Ovary
  • Lung
  • Colon
  • Breast
  • Skin
  • Other Cancers


By Types

  • Monoclonal Antibodies
  • Linkers
  • Drugs/Toxins


By End Users

  • Medical Physicist
  • Cancer Research Scientist
  • Oncologist


Regional Analysis of Antibody Drug Conjugate Market:

Globally North America is the largest market for Antibody Drug Conjugate. The North American market for Antibody Drug Conjugate is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. Europe is the second-largest market for Antibody Drug Conjugate which is expected to grow at a CAGR of XX%


Taste the market data and market information presented through more than 70 market data tables and figures spread in 140 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Antibody Drug Conjugate Market Research Report- Forecast To 2027


Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Value/Supply Chain Analysis

5.2 Porter’s 5 Forces Analysis



Browse Report @


The market is classified and analyzed on the basis of various segments including geographies, which consist of; Americas, Europe, Asia-Pacific, and Middle East & Africa. Out of all, North America accounts for the largest share in the market. In addition, Europe and Asia-Pacific is the fastest growing segment in the Antibody Drug Conjugate market, owing to factors such as increasing healthcare expenditure and improving healthcare infrastructures are further spurring the demand of Antibody Drug Conjugate in various regions.


Related Report

Global Vaccine Conjugates Market Information by Type (Haemophilus B, Monovalent, Multivalent, Others), by Indication (Influenza, Pneumococcal, Meningococcal, Others) – Forecast to 2027


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.



Akash Anand,

Market Research Future

+1 646 845 9312


Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.